Korea Pharma Co Ltd (032300)

Currency in KRW
14,750
+20(+0.14%)
Closed·
032300 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
032300 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
14,51014,820
52 wk Range
13,05024,650
Key Statistics
Bid/Ask
14,730.00 / 14,750.00
Prev. Close
14,730
Open
14,650
Day's Range
14,510-14,820
52 wk Range
13,050-24,650
Volume
4.88K
Average Volume (3m)
30.52K
1-Year Change
-15.76%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
032300 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell

Korea Pharma Co Ltd Company Profile

KOREA PHARMA Co., Ltd. . produces pharmaceutical drugs. The company offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, skeltal muscle relaxants, and specialty drugs, as well as multivitamins, and vitamin B1, etc. KOREA PHARMA Co., Ltd. was founded in 1974 and is based in Seoul, South Korea.

Employees
134

Compare 032300 to Peers and Sector

Metrics to compare
032300
Peers
Sector
Relationship
P/E Ratio
54.0x4.2x−0.5x
PEG Ratio
0.450.010.00
Price/Book
2.3x0.7x2.6x
Price / LTM Sales
2.0x0.8x3.3x
Upside (Analyst Target)
-0.0%43.5%
Fair Value Upside
Unlock16.6%6.8%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 273.96%
Dividend Yield
0.34%
Industry Median 0.93%
Annualised payout
50.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 14, 2025
EPS / Forecast
47.00 / --
Revenue / Forecast
20.79B / --
EPS Revisions
Last 90 days

032300 Income Statement

FAQ

What Stock Exchange Does Korea Pharm Trade On?

Korea Pharm is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Korea Pharm?

The stock symbol for Korea Pharm is "032300."

What Is the Korea Pharm Market Cap?

As of today, Korea Pharm market cap is 160.87B.

What Is Korea Pharm's Earnings Per Share (TTM)?

The Korea Pharm EPS (TTM) is 273.96.

From a Technical Analysis Perspective, Is 032300 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Korea Pharm Stock Split?

Korea Pharm has split 0 times.

How Many Employees Does Korea Pharm Have?

Korea Pharm has 134 employees.

What is the current trading status of Korea Pharm (032300)?

As of 09 Aug 2025, Korea Pharm (032300) is trading at a price of 14,750.00, with a previous close of 14,730.00. The stock has fluctuated within a day range of 14,510.00 to 14,820.00, while its 52-week range spans from 13,050.00 to 24,650.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.